Dana Investment Advisors, Inc.

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1427514 BROOKFIELD, WI

Position in LGND

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$13,822,568

+$701,867 QoQ

Shares Held

69,234

-0.2% QoQ

Ownership

0.345%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 61.45679868272814.ToString("F0")% Shared 0.ToString("F0")% None 38.54320131727186.ToString("F0")%

Healthcare · as of Mar 31, 2026

Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. LGND ranks #1 (39.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc This page	69,234	$13,822,568
2	REGN	Regeneron Pharmaceuticals, Inc.	8,397	$6,487,858
3	AXSM	Axsome Therapeutics, Inc.	26,379	$4,458,578
4	VKTX	Viking Therapeutics, Inc.	59,756	$1,944,460
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,197	$1,673,533
6	TGTX	Tg Therapeutics, Inc.	43,954	$1,460,151
7	ZYME	Zymeworks Inc.	56,107	$1,404,919
8	IONS	Ionis Pharmaceuticals Inc	18,487	$1,388,188

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,822,568	69,234	-0.2%	Shares	Sole	2026-05-14
2025-12-31	$13,120,701	69,396	-4.5%	Shares	Sole	2026-02-05
2025-09-30	$12,870,815	72,659	-0.7%	Shares	Sole	2025-11-10
2025-06-30	$8,317,851	73,169	-1.5%	Shares	Sole	2025-08-13
2025-03-31	$7,813,373	74,314	-2.5%	Shares	Sole	2025-05-15
2024-12-31	$8,167,937	76,229	-5.4%	Shares	Sole	2025-02-06
2024-09-30	$8,067,454	80,602	-10.5%	Shares	Sole	2024-11-13
2024-06-30	$7,588,118	90,056	+18.7%	Shares	Sole	2024-08-27
2024-03-31	$5,544,342	75,846	+323.6%	Shares	Sole	2024-05-15
2020-09-30	$1,064,575	17,903	-6.3%	Shares	Sole	2020-11-10
2020-06-30	$1,333,198	19,107	-7.3%	Shares	Sole	2020-08-11
2020-03-31	$934,743	20,605	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.